Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

13.0K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

959
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
959
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strategies for Identifying Molecules of Interest in Large Chemical Spaces.

Journal of chemical information and modeling·2026
Same author

Allosteric disordering of eIF2B regulates the integrated stress response.

Nature chemical biology·2026
Same author

Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer model.

Nature communications·2026
Same author

Publisher Correction: Deep-learning-based virtual screening of antibacterial compounds.

Nature biotechnology·2025
Same author

Deep-learning-based virtual screening of antibacterial compounds.

Nature biotechnology·2025
Same author

Discovery of Novel Isofunctional SARS-CoV‑2 NSP14 RNA Cap Methyltransferase Inhibitors by Structure-Based Virtual Screening.

ACS medicinal chemistry letters·2025

Related Experiment Video

Updated: Aug 23, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.4K

Chemical space docking enables large-scale structure-based virtual screening to discover ROCK1 kinase inhibitors.

Paul Beroza1, James J Crawford2, Oleg Ganichkin3

  • 1Discovery Chemistry, Genentech, South San Francisco, USA. berozap@gene.com.

Nature Communications
|October 28, 2022
PubMed
Summary

Drug discovery needs faster searching. A new virtual screening method uses molecular docking to rapidly identify potential drug leads from massive compound libraries, significantly speeding up the process.

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

465
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

Related Experiment Videos

Last Updated: Aug 23, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.4K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

465
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Drug Discovery

Background:

  • The increasing size of compound libraries for drug discovery necessitates advanced search technologies.
  • Efficiently screening billions of molecules is a significant challenge in identifying novel drug leads.

Purpose of the Study:

  • To develop and apply an efficient structure-based virtual screening method for drug lead identification.
  • To identify inhibitors of ROCK1 from a large, commercially available compound library.

Main Methods:

  • A novel virtual screening approach was developed, avoiding full library enumeration.
  • Molecular docking, utilizing protein structural information, was employed to evaluate compounds.
  • The method was applied to screen nearly one billion compounds for ROCK1 inhibitors.

Main Results:

  • The virtual screening successfully identified potential ROCK1 inhibitors.
  • Of 69 purchased compounds, 39% exhibited Ki values below 10 µM.
  • X-ray crystallography confirmed the docked poses of two identified lead compounds.

Conclusions:

  • The developed structure-based virtual screening method is highly efficient for exploring vast chemical spaces.
  • This approach significantly accelerates the identification of drug leads compared to traditional docking methods.
  • The method demonstrates a scalable and effective strategy for hit identification in drug discovery.